María José
María José Bermejo Osés, Barberà Del Vallès-Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090269294 | Fragrance Precursor - The invention relates to a compound of the following formula (I) X—CR | 10-29-2009 |
María José Bermejo Osés, Barberà Del Vallès-Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090269294 | Fragrance Precursor - The invention relates to a compound of the following formula (I) X—CR | 10-29-2009 |
María José Bermejo Osés, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100035781 | Composition which Contains a Mixture of Mono-, Di and Triglycerides and Glycerine - The present invention relates to a composition which contains a mixture of alkoxylated mono-, di-, and triglycerides and glycerine of formula wherein R′ represents H or CH3, and each one of m, n, or l represents, independently, a number from 0 to 20, the sum of m, n, and l being in the range of 1.5 to 20, characterized in that in the acyl group represented by —CO—R, R represents an alkyl or alkenyl group, linear or branched, of 6 to 11 carbon atoms, and the proportion by weight (i)+(ii)+(iii)/(iv) is in the range of 2.0:0.5 to 0.5:3; and to a method for the preparation of said composition, the detergent compositions which contain said compositions, and the use of said composition as surfactant or co-surfactant in the detergent compositions, particularly in detergent compositions, especially, but not exclusively, suitable for washing fabrics, suitable for manual dishwashing, for washing the hair or for personal hygiene. | 02-11-2010 |
María José Castello Llopis, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100242133 | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE - The invention relates to the use of a mutation for the generation of virus-resistant mutant plants and, specifically, to the use of mutation 8.1 of the AtDBP1 gene of | 09-23-2010 |
María José Castello Llopis, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100242133 | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE - The invention relates to the use of a mutation for the generation of virus-resistant mutant plants and, specifically, to the use of mutation 8.1 of the AtDBP1 gene of | 09-23-2010 |
María José DÍaz CabaÑas, Valencia ES
Patent application number | Description | Published |
---|---|---|
20080267860 | Crystalline Microporous Material Of Zeolitic Nature - A crystalline microporous material of zeolitic nature (ITQ-41) having in its calcined form a chemical composition represented by the empirical formula: | 10-30-2008 |
20090124484 | Microporous Crystalline Material, Zeolite ITQ-33, Method of Preparation and Use - The invention relates to a microporous crystalline material which is characterised in that it has the following chemical composition in the calcined state: X | 05-14-2009 |
20090220661 | MICROPOROUS CRYSTALLINE MATERIAL, ZEOLITE ITQ-37, PREPARATION METHOD AND USE - The present invention relates to a microporous crystalline material characterized in that it has the following chemical composition in the calcined from: | 09-03-2009 |
20100025299 | Catalyst based on solid microporous crystalline material and method of improving diesel fraction quality using said catalyst - The invention relates to a catalyst consisting of at least: one matrix comprising at least one oxide which is selected from an amorphous oxide, an oxide with low crystallinity and a mixture of both; at least one solid microporous crystalline material which, in the calcined and anhydrous state, has the molar compositions X | 02-04-2010 |
María José DÍaz CabaÑas, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100025299 | Catalyst based on solid microporous crystalline material and method of improving diesel fraction quality using said catalyst - The invention relates to a catalyst consisting of at least: one matrix comprising at least one oxide which is selected from an amorphous oxide, an oxide with low crystallinity and a mixture of both; at least one solid microporous crystalline material which, in the calcined and anhydrous state, has the molar compositions X | 02-04-2010 |
María José Gil Morrio, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100115668 | Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the OCP3 gene of | 05-06-2010 |
María José Gil Morrio, Valencia ES
Patent application number | Description | Published |
---|---|---|
20090106858 | Isolation and Characterization of the Csb3-1 Mutant of Arabidopsis Thaliana and Use Thereof as a Regulator of Resistance in Plants to Diseases Caused by Biotrophic Pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the identification and characterization of the csb3-1 mutant of | 04-23-2009 |
20100115668 | Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the OCP3 gene of | 05-06-2010 |
María José Guillén Navarro, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130266666 | Combination Therapy with an Antitumor Alkaloid - The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer. | 10-10-2013 |
María José Montes Pita, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130152914 | PANEL WITH LONGITUDINAL MIRRORS FOR A SOLAR POWER PLANT - A receiver for a solar power plant with mirrors ( | 06-20-2013 |
María José Sanchez Gallardo, Alicante ES
Patent application number | Description | Published |
---|---|---|
20110170949 | REMOVABLE PNEUMATIC MARKER WITH UNDERGROUND ANCHORING - A description is given of a bollard designed specifically for signalling in places through which, road traffic passes, both in cities, towns and villages and on roads and motorways. The bollard comprises two separate elements, of which one provides lower anchorage to the ground, and is stiff, and the other is the section of the bollard itself, and is elastic, flexible and capable of being fitted to the lower element by means of a bayonet configuration. In the rapid recovery version, the upper flexible element incorporates an inflatable pneumatic ball inside. The whole bollard has a lid that can be fitted to the lower anchoring element when the upper one has been removed, this lid being shaped to remain flush, coupled, to the surface of the ground. | 07-14-2011 |
María José Tamés Alonso, Donostia (gipuzkoa) ES
Patent application number | Description | Published |
---|---|---|
20120318402 | Machine and Method for the Automatic Preparation of Intravenous Medication - A machine for the automatic preparation of an intravenous medication is provided. In one implementation the machine has a chamber with a starting products area where at least one receptacle is disposed with a base product from which the intravenous medication is generated, a transfer tools area where at least one transfer tool that is used to prepare the required medication is disposed, a prepared products area where at least one container to house the prepared medication is disposed, and a first robot to handle the transfer tool, the first robot being adapted to transport the transfer tool between the transfer tools area, the starting products area and the prepared products area in order to prepare the intravenous medication. | 12-20-2012 |